Literature DB >> 18197169

Complement evasion by human pathogens.

John D Lambris1, Daniel Ricklin, Brian V Geisbrecht.   

Abstract

The human immune system has developed an elaborate network of cascades for dealing with microbial intruders. Owing to its ability to rapidly recognize and eliminate microorganisms, the complement system is an essential and efficient component of this machinery. However, many pathogenic organisms have found ways to escape the attack of complement through a range of different mechanisms. Recent discoveries in this field have provided important insights into these processes on a molecular level. These vital developments could augment our knowledge of the pathology and treatment of infectious and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197169      PMCID: PMC2814840          DOI: 10.1038/nrmicro1824

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  100 in total

1.  Pro-inflammatory complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein.

Authors:  J Daly; G J Kotwal
Journal:  Neurobiol Aging       Date:  1998 Nov-Dec       Impact factor: 4.673

Review 2.  Surface protein adhesins of Staphylococcus aureus.

Authors:  T J Foster; M Höök
Journal:  Trends Microbiol       Date:  1998-12       Impact factor: 17.079

Review 3.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

4.  A second IgG-binding protein in Staphylococcus aureus.

Authors:  L Zhang; K Jacobsson; J Vasi; M Lindberg; L Frykberg
Journal:  Microbiology (Reading)       Date:  1998-04       Impact factor: 2.777

5.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

Authors:  Ann H Rux; Huan Lou; John D Lambris; Harvey M Friedman; Roselyn J Eisenberg; Gary H Cohen
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

7.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins.

Authors:  Jayati Mullick; John Bernet; Akhilesh K Singh; John D Lambris; Arvind Sahu
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 8.  Virus complement evasion strategies.

Authors:  Herman W Favoreel; Gerlinde R Van de Walle; Hans J Nauwynck; Maurice B Pensaert
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

9.  The yeast Candida albicans binds complement regulators factor H and FHL-1.

Authors:  T Meri; A Hartmann; D Lenk; R Eck; R Würzner; J Hellwage; S Meri; P F Zipfel
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 10.  Viral interference with antibody and complement.

Authors:  J Lubinski; T Nagashunmugam; H M Friedman
Journal:  Semin Cell Dev Biol       Date:  1998-06       Impact factor: 7.727

View more
  317 in total

1.  Immune evasion strategies of Porphyromonas gingivalis.

Authors:  George Hajishengallis
Journal:  J Oral Biosci       Date:  2011

Review 2.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

Review 3.  Bacterial RNA thermometers: molecular zippers and switches.

Authors:  Jens Kortmann; Franz Narberhaus
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 4.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

5.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

6.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

7.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

8.  The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.

Authors:  Jordan L Woehl; Kasra X Ramyar; Benjamin B Katz; John K Walker; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

9.  Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.

Authors:  Sean P Riley; Jennifer L Patterson; Samantha Nava; Juan J Martinez
Journal:  Cell Microbiol       Date:  2013-12-13       Impact factor: 3.715

10.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.